RxDoctor Payments Data

Scott Peterson, MD

Family Medicine · Orem, UTNPI 1427008812

Payments from drug & device makers

$5,655in general payments, 2019–2025

Across 343 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$861
  • AbbVie$777
  • Lilly USA, LLC$539
  • AstraZeneca$485
  • Merck$425
  • Amgen$376
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$5,648100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,655 in reported general payments places this provider in the 80th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$104,833
Medicare patients
215
Services billed
2,235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin95$130,086
EliquisApixaban61$75,546
OzempicSemaglutide33$63,248
MyrbetriqMirabegron48$47,456
TrulicityDulaglutide29$41,404
FarxigaDapagliflozin Propanediol35$41,052
JanuviaSitagliptin Phosphate28$25,055
Synjardy XrEmpagliflozin/Metformin Hcl11$6,576
Atorvastatin Calcium436$6,456
TrintellixVortioxetine Hydrobromide11$5,195
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$4,356
Levothyroxine Sodium292$4,069
Fluticasone-SalmeterolFluticasone Propion/Salmeterol29$3,309
Omeprazole156$3,174
Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide64$3,042

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr$861$136,662106 claims
PfizerEliquis$204$75,54661 claims
Novo NordiskOzempic$320$63,24833 claims
Astellas Pharma US IncMyrbetriq$353$47,45648 claims
Lilly USA, LLCTrulicity$539$41,40429 claims
AstraZenecaFarxiga$485$41,05235 claims
MerckJanuvia, Asmanex$425$27,09646 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 928 family medicine providers in Utah.

Other family medicine in Orem

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →